These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12434968)
1. Drug rationing in the UK. Wood P Br J Gen Pract; 2002 Nov; 52(484):941-2. PubMed ID: 12434968 [No Abstract] [Full Text] [Related]
2. [Problems and prospects of beta-interferon and copaxone++ application in the treatment of multiple sclerosis]. Gusev EI; Boĭko AN; Pozer Ch Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(4):33-6. PubMed ID: 10319395 [No Abstract] [Full Text] [Related]
3. [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis]. Zavalishin IA; Peresedova AV; Stoĭda NI; Rebrova Oi; Zakharova MN; Adarcheva LS; Niazbekova AS; Askarova LSh; Baĭdina EV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():111-5. PubMed ID: 17172245 [TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate for relapsing multiple sclerosis. Med Lett Drugs Ther; 1997 Jul; 39(1004):61-2. PubMed ID: 9217693 [No Abstract] [Full Text] [Related]
5. Immunomodulatory treatment of MS in Slovenia. Sega-Jazbec S Clin Neurol Neurosurg; 2002 Jul; 104(3):249-50. PubMed ID: 12127663 [No Abstract] [Full Text] [Related]
6. Glatiramer acetate: evidence for a dual mechanism of action. Blanchette F; Neuhaus O J Neurol; 2008 Mar; 255 Suppl 1():26-36. PubMed ID: 18317674 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostics and drug therapy of multiple sclerosis]. Suomen Neurologinen Yhdistys ry Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889 [No Abstract] [Full Text] [Related]
8. Confusion over UK beta-interferon "trials". Dean M Lancet; 2001 Nov; 358(9293):1619. PubMed ID: 11716901 [No Abstract] [Full Text] [Related]
9. Current therapy of multiple sclerosis. Johnson KP; Baringer JR Hosp Pract (1995); 2001 Apr; 36(4):21-2, 25-8; discussion 28-9. PubMed ID: 11327342 [TBL] [Abstract][Full Text] [Related]
10. Access denied. While the decision over beta-interferon prescribing hangs in the balance, one thing's for certain--nurses will be left to pick up the pieces. Thomas S Nurs Stand; 2000 Jul 19-25; 14(44):20. PubMed ID: 11975272 [No Abstract] [Full Text] [Related]
11. NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence. Hartung HP Lancet; 2000 Sep; 356(9235):1114. PubMed ID: 11009171 [No Abstract] [Full Text] [Related]
13. Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial. de Seze J; Edan G; Labalette M; Dessaint JP; Vermersch P Ann Neurol; 2000 May; 47(5):686. PubMed ID: 10805349 [No Abstract] [Full Text] [Related]
14. Management of relapsing/remitting multiple sclerosis with copolymer 1 (Copaxone). Johnson KP Mult Scler; 1996 Jul; 1(6):325-6. PubMed ID: 9345409 [TBL] [Abstract][Full Text] [Related]
15. The use of interferon Beta and glatiramer acetate in multiple sclerosis. Goodin DS Semin Neurol; 2013 Feb; 33(1):13-25. PubMed ID: 23709209 [TBL] [Abstract][Full Text] [Related]
16. In vitro glatiramer acetate treatment of brain endothelium does not reduce adhesion phenomena. Dufour A; Corsini E; Gelati M; Massa G; Tarcic N; Salmaggi A Ann Neurol; 2000 May; 47(5):680-2. PubMed ID: 10805344 [No Abstract] [Full Text] [Related]
17. Glatiramer: a second look. With longer follow-up: still no proven benefit in multiple sclerosis. Prescrire Int; 2009 Dec; 18(104):252. PubMed ID: 20025092 [No Abstract] [Full Text] [Related]
18. Beta interferon, NICE, and rationing. Kernick D Br J Gen Pract; 2002 Sep; 52(482):784-5. PubMed ID: 12236297 [No Abstract] [Full Text] [Related]
19. [A comparative evaluation of immunomodulating drugs in the treatment of remitting multiple sclerosis]. Zvartau ME; Kaon K; Lisak RF; Kan OA; Skoromets AA Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(7):66-71. PubMed ID: 15347038 [No Abstract] [Full Text] [Related]
20. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS. Pöllmann W; Erasmus LP; Feneberg W; Straube A Neurology; 2006 Jan; 66(2):275-7. PubMed ID: 16434675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]